Abstracts

Abstracts found: 6467

A validated model of the neutralising antibody-efficacy relationship for monoclonal antibody pre-exposure prophylaxis against COVID-19

Abstract number: 11378
Poster: Drug/Disease Modelling - Other Topics
Rhiannon Edge¹, Sam Matthews¹, John Pura2, Bahar Ahani3, Anastasia Aksyuk3, Lindsay Clegg4, Mark Esser3, Lee-Jah Chang3, Ian Hirsch1, Tonya Villafana3, John Perez3, Oleg Stepanov5, Katie Streicher3, Tom White1, Taylor Cohen3, Dean Follmann6, Peter Gilbert7, Seth Seegobin1
2025 - Thessaloniki - Greece

Cabotegravir Population Pharmacokinetic Analysis of Adult and Adolescents pooled population who are living with HIV or at risk for HIV and receiving HIV pre-exposure prophylaxis (PrEP)

Abstract number: 11371
Poster: Drug/Disease Modelling - Paediatrics
Yu-Wei Lin1,2, Amy S. Y. Cheung1,2, Isabelle Deprez1,2, Susan Ford2, Jon Collins3, Rashmi Mehta2, Mark Bush3, Kelong Han2, Cindy McCoig4, Conn M. Harrington3, Lionel Tan5, Aditya Gaur6, Carolyn Bolton7, Lynda Stranix-Chibanda8, Sybil Hosek9, Mark Marzinke10, Brookie Best11, Edmund Capparelli11, . for IMPAACT 2017 Team12, . for HPTN 084-01 Study Team13, . for HPTN 083-01 Study Team13
2025 - Thessaloniki - Greece

Modelling framework to evaluate anti-viral PROTACs

Abstract number: 11372
Poster: Drug/Disease Modelling - Infection
Yi-han Chien1, You-Ting Chen1, Judith Röske2, Kaixuan Zhang2, Graham P. Marsh3, Sebenzile Myeni4, Hannah J. Maple3, Alex Moloney3, Marjolein Kikkert4, Rolf Hilgenfeld2,5, Mark Brönstrup1,6, Katharina Rox1,6
2025 - Thessaloniki - Greece